Recently, researchers found that PD-L1 expression of CD8+ effector T cells was significantly higher in aged mice than younger mice and anti-PD-L1 immunotherapy led to a decrease in cell proliferation in vitro and a reduction in anti-tumor immune response in older hosts, as compared to their effects in young mouse lymphoma models (86, 87). This evidence concerns the gene CD274 and neoplasm.